Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

2006 drug approvals: finding the niche

An Erratum to this article was published on 01 March 2007

Abstract

Companies move towards niche products to boost productivity.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: FDA drug approvals.
Figure 2: Priority reviews and orphan drugs.
Figure 3: 2006 Drug approvals by therapeutic area.
Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Owens, J. 2006 drug approvals: finding the niche. Nat Rev Drug Discov 6, 99–101 (2007). https://doi.org/10.1038/nrd2247

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2247

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing